1. Arcadia Biosciences Doubles Retail Footprint for GoodWheat™ Pasta

    — Better-for-you pasta brand is now available in more than 1,000 stores within six months of launch — DAVIS, Calif. (December 8, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced its GoodWheat™ pasta is now available in more than 1,000 retail locations coast-to-coast, doubling distribution in the…Continue Reading »
  2. Arcadia Biosciences Announces CFO Transition

    — Pam Haley to be replaced by Thomas J. Schaefer effective January 3, 2023 — DAVIS, Calif. (November 30, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CFO Pam Haley will be leaving the company and will be replaced by Thomas J. Schaefer,…Continue Reading »
  3. GoodWheat pasta in nearly 1,000 stores

    DAVIS, CALIF. — Executives of Arcadia Biosciences aimed to have the company’s GoodWheat pasta in more than 1,000 retail outlets by the end of the fiscal year. The goal was in reach by the third quarter’s end on Sept. 30. GoodWheat launched in the retail channel in May and on Amazon.com in mid-August.Continue Reading »
  4. Arcadia Biosciences Announces Strong Third Quarter 2022 Financial Results and Business Highlights

    — GoodWheat™ Pasta distribution doubles from Q2 — Gross margins improve to 28% — Streamlined operations focus on higher-margin brands  DAVIS, Calif. (November 10, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2022….Continue Reading »
  5. Arcadia Biosciences Announces Date of Third Quarter 2022 Financial Results and Business Highlights Conference Call

    DAVIS, Calif. (October 27, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter and first nine months of 2022 after market close on November 10, 2022. The company has scheduled a…Continue Reading »
  6. Arcadia Biosciences to Participate in Upcoming Investor Conferences

    DAVIS, Calif. (August 31, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and Pam Haley, CFO, will be participating in two investor conferences during the month of September. H.C. Wainwright 24th Annual Global Investment Conference. Arcadia will…Continue Reading »
  7. Arcadia Biosciences Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market

    DAVIS, Calif. (August 16, 2022) — Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced the closing of its previously announced registered direct offering of 4,722,506 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.05876 per share, priced…Continue Reading »
  8. Arcadia’s growth plan to rely on GoodWheat

    DAVIS, CALIF. — Recently launched GoodWheat pasta will serve as a driving force behind Arcadia Bioscience’s Project Greenfield three-year growth plan. Company executives explained Project Greenfield along with plans to divest in other areas, including the hemp business, in an Aug. 11 earnings call to discuss second-quarter earnings. Arcadia launched GoodWheat pasta at retail during…Continue Reading »
  9. Arcadia Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market

    DAVIS, Calif. (August 12, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that it has entered into securities purchase agreements with a single healthcare-focused institutional investor for the purchase and sale of 4,722,506 shares of its common stock (or common stock equivalents) at…Continue Reading »